Do you want to read an article? Please log in or register.
FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
Migraine and Headache
Related content
RECOMMENDED
Migraine and Headache
A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache.
Winner PK, Kabbouche M, Yonker M, Wangsadipura V, Lum A, Brin MF
doi: 10.1111/head.13754.
Migraine and Headache
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
J Headache Pain.
Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A
doi: 10.1186/s10194-018-0840-8.
RECOMMENDED
Migraine and Headache
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
doi: 10.1186/s10194-018-0921-8.
Migraine and Headache
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
Headache.
Detke HC, Millen BA, Zhang Q, Samaan K, Ailani J, Dodick DW, Aurora SK
doi: 10.1111/head.13691.
Migraine and Headache
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache
Headache
Marmura MJ, Diener HC, Cowan RP, Tepper SJ, Diamond ML, Starling AJ, Hirman J, Mehta L, Brevig T, Cady R
doi: 10.1111/head.14206
Migraine and Headache
A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache
Cephalalgia.
Grazzi L, Raggi A, D'Amico D, Sansone E, Leonardi M, Andrasik F, Gucciardi A, Guido D, D'Andrea G
doi: 10.1177/0333102418801584.
Migraine and Headache
Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ)
Headache.
Hareendran A, Skalicky A, Mannix S, Lavoie S, Desai P, Bayliss M, Thach AV, Mikol DD, Buse DC
doi: 10.1111/head.13420.
Migraine and Headache
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Headache
Kawata AK, Shah N, Poon JL, Shaffer S, Sapra S, Wilcox TK, Shah S, Tepper SJ, Dodick DW, Lipton RB
doi: 10.1111/head.14053
Migraine and Headache
The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Headache
Lipton RB, Seng EK, Chu MK, Reed ML, Fanning KM, Adams AM, Buse DC
doi: 10.1111/head.13914